Altered Hepatic Metabolism in Down Syndrome

This multi-omic study of over 400 individuals with Down syndrome (Trisomy 21) identified broad metabolic changes including increased bile acid levels and markers of liver dysfunction. Using mouse models and transcriptomic analysis, researchers demonstrated that dietary fat modulation significantly impacts hepatic gene expression, bile acid metabolism, and liver pathology in Down syndrome.